Encompass Health Corporation - EHC STOCK NEWS

Encompass Health Corporation (EHC) announced amendments to its consent solicitation for holders of 4.500% Senior Notes due 2028, 4.750% Senior Notes due 2030, and 4.625% Senior Notes due 2031. The amendments will increase aggregate consent payments to $16 million for the 2028 and 2030 Notes, and $8 million for the 2031 Notes. The consent solicitation will expire on January 24, 2022, at 5:00 p.m. New York City time. Holders should review the full statement regarding potential tax implications and consult their advisors. The company retains the right to modify or terminate the solicitation.

Encompass Health Corporation (NYSE: EHC) announced its plan to spin off its home health and hospice business, creating an independent publicly traded entity called Enhabit Home Health & Hospice. This separation aims to enhance operational flexibility and focus for both businesses. Expected to be tax-free for shareholders, the spin-off will occur in the first half of 2022, pending certain regulatory approvals. This move aims to enable each company to better align its capital structure and investment policies with its specific operational needs.

Encompass Health Corporation (NYSE: EHC) announced an amendment to its consent solicitation for holders of its Senior Notes due 2028, 2030, and 2031. The company will offer aggregate consent payments totaling $30 million—$12 million for each of the 2028 and 2030 Notes, and $6 million for the 2031 Notes. The deadline for investors to respond is set for 5:00 p.m. New York City time on January 24, 2022. The company has made clarifications to its restricted payments basket under the indenture and retains the right to modify or terminate the solicitation at any time.

Encompass Health Corporation (NYSE: EHC) has extended the solicitation of consents from holders of its Senior Notes due 2028, 2030, and 2031. The expiration for the consent solicitation is now set for January 24, 2022, at 5:00 p.m. New York City time. Holders who have already delivered their consents do not need to take further action. The company reserves the right to modify or terminate the solicitation at any time. Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC are the solicitation agents, while Global Bondholder Services Corporation is serving as the information agent.

Encompass Health Corp. (NYSE: EHC) will report its fourth quarter results for 2021 on Feb. 1, 2022, after market closure. An investor conference call is scheduled for Feb. 2, 2022, at 10 a.m. ET, where the results will be discussed. The call can be accessed by dialing 866-342-8591 (international: 203-518-9713) and using conference ID EHCQ421. Encompass Health operates 145 hospitals and 251 home health locations across 42 states and Puerto Rico, focusing on integrated healthcare services.

Encompass Health Corp. (NYSE: EHC) and Saint Alphonsus Health System announced a new joint venture for home health and hospice services in Idaho, effective January 1, 2022. This collaboration expands upon their existing joint venture for inpatient rehabilitation services established in 2019. The partnership aims to enhance the quality of patient care while reducing hospital readmissions, leveraging Encompass Health's expertise in home health and hospice.

Encompass Health Corporation (NYSE: EHC) announced on December 16, 2021, that it has received consents from holders of its 5.75% Senior Notes due 2025 for proposed amendments, completed on December 15, 2021. The amendments will proceed if a consent payment is made. Additionally, the company is extending the consent solicitation for holders of its 4.500%, 4.750%, and 4.625% Senior Notes, now expiring on January 12, 2022. All other terms remain unchanged, and the company retains the right to modify or terminate the solicitation at any time.

Encompass Health Corp. (NYSE: EHC) announced plans to establish a 40-bed inpatient rehabilitation hospital in Strongsville, Ohio, aimed at enhancing patient access to rehabilitation services in the Cleveland area. This facility will cater to patients recovering from conditions such as strokes and spinal cord injuries, and will provide services including 24-hour nursing care and various therapies. The construction timeline is yet to be announced. Currently, Encompass Health operates four inpatient rehabilitation hospitals in Ohio, indicating its commitment to expanding its national healthcare network.

Encompass Health Corporation (NYSE: EHC) announced a Consent Solicitation on December 9, 2021, seeking approval from holders of its Senior Notes for proposed amendments to facilitate the separation of its home health and hospice business, expected in H1 2022. The amendments aim to allow a spin-off contingent upon maintaining a consolidated net leverage of no more than 3.5 to 1.0. Consent will expire on December 15, 2021, with cash payments for valid consents ranging from $2.50 to $5.00 per $1,000 depending on the note series. The success of this solicitation is uncertain.